Dr. Carr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Kimmel Cancer Center. 111 S 11th St
Suite 4240
Philadelphia, PA 19107Phone+1 412-980-4518Fax+1 215-955-2340
Summary
- Specialist in primary tumors of the liver-HCC, CCC and NET
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1977 - 1979
- University of LondonMD, Medicine, 1964 - 1967
- Imperial College London School of MedicineClass of 1967, PhD
Certifications & Licensure
- PA State Medical License 1989 - 2024
- CA State Medical License 1979 - 2019
- WI State Medical License 1979 - 2015
Clinical Trials
Publications & Presentations
PubMed
- 18 citationsC-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.Brian I. Carr, Hikmet Akkiz, Guerra, Oğuz Üsküdar, Sedef Kuran
Clinical Practice. 2018-01-01 - 16 citationsSerum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma.Hikmet Akkiz, Brian I. Carr, Harika Gozukara Bag, Ümit Karaoğullarından, Kendal Yalcin
International Journal of Clinical Practice. 2021-02-01 - 172 citationsLiver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system.Shunzaburo Iwatsuki, Igor Dvorchik, J. Wallis Marsh, Juan Madariaga, Brian I. Carr
Journal of the American College of Surgeons. 2000-10-01
Grant Support
- K Vitamins- A New Class Of Liver Cell Growth InhibitorsNational Cancer Institute2007–2008
- K Vitamins- A New Class Of Liver Cell Growth InhibitorsNational Cancer Institute2004–2006
- K Vitamins--A New Class Of Liver Cell Growth InhibitorsNational Cancer Institute2000–2003
- Prognostic Factors In Human HepatomaNational Cancer Institute1992
- TGFB Receptors In HepatocarcinogenesisNational Cancer Institute1989–1992
- TGFB Receptors In HepatocarcinogenesisNational Cancer Institute1988–1989
Professional Memberships
- Member
- Member
Other Languages
- French, Italian, Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: